Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Ny studie: Så kan sömnbrist ge övervikt

Forskare vid Uppsala universitet visar i en studie att redan efter en natts sömnbrist påverkas vävnaders ämnesomsättning och reglering av genuttrycket.

"Det handlar ju om liv, även efter corona"

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Namn på ersättningsläkemedel kan förvirra

Ersättningsmediciner är bra för landstingens ekonomi. Men samtidigt riskerar patienter att inte känna igen sina mediciner, när det står andra namn på förpacknin...

Changeable proteins cause nerve disease

An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Higher performance UV-Vis spectrophotometry with double beams

The Biochrom Libra series of UV-Vis spectrophotometers now features double beams and variable bandwidths.

Globalt uttalande

Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.

GMP-anläggning klar i Lund

Lundabaserade Xintela meddelar att den egna GMP-anläggningen på Medicon village är färdigbyggd.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Höjer bud på Actelion

Johnson & Johnson diskuterar förvärv av det schweiziska läkemedelsbolaget, och uppges nu ha höjt sitt bud.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

De väljs in i IVA

Flera nya ledamöter ur life science och medtech-leden.

New faces in Pronova Biopharma team

The Norwegian company Pronova Biopharma has recently changed the management team structure.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Vill sälja USA-verksamheten

Enligt rykten diskuterar Meda en försäljning av sin amerikanska verksamhet.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

New Nordic biotech company

The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.

Enjoy Stockholm - the capital of Scandinavia

Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...